… Substance P (SP) is implicated in brain inflammation. We … between serum SP concentrations
and functional outcome of … of serum SP in the acute phase of ICH on functional outcome …

… Thus, the novel aspects our study include that serum substance … serum substance P levels
were associated with early mortality controlling for other variables, and that serum substance …

… Thus, although we were able to conclude that an association between serum … serum levels
of SP are the cause of a poor outcome in MMCAI patients. Fourth, we did not record serum …

… The detection has highly sensitivity in the functional group of the … and lipid functional group
disturbance because of substance … The outcomes of the spectra were obtained on scanning …

… Taken together, all these findings suggest that serum SP levels may be of great … outcome
[44-46]. In fact, treatment of rats with a NK1R antagonist after TBI improved functional outcome […

… Substance P (SP) is a peptide of the tachykinins family involved in the inflammatory response.
… a possible relationship between serum SP levels and patient outcome in the largest cohort …

… context, the assessment of substances in the biological fluids … in response to SCI and their
impact on clinical outcome. … and functional outcomes.29, 30, 31 We found that serum GDNF …

… serum substance P levels on day 1 of TBI in 100 of those patients, 17 and in this work, we
measured serum substance P levels on days 1, 4 and 8 of TBI in 124 patients. Serum samples …

… The aim of the is study is to examine the role of serum substance P … SP serum values were
obtained by means of an ELISA … Elevated serum SP is a common feature of RA patients, which …

… for both PFAS serum measurements and health outcomes instills a … serum PFAS and
outcome measurement, as we describe the association between serum PFAS and kidney function …